(Date:11/21/2008)...erapies for preterm labor , , FRIDAY, No...found the switch that activates the uterine muscle...t may lead to therapies for preterm labor. , T...n IP on the surface of these uterine muscle cells,.... , But researchers from Dartmouth Medical Sch...
(Date:11/21/2008)... University of Texas Health Science Center at Hous... in Aging Studies (TEXAS), to promote geriatrics t...llion award from the Donald W. Reynolds Foundation... allow us to teach geriatric medicine principles t... practicing physicians. With the reach of Lyndon B...
(Date:11/21/2008)...RNewswire-USNewswire/ -- The Generic,Pharmaceutic...ment today from,GPhA President and CEO Kathleen J...) roundtable on "Emerging Health Care Competition ... the FTC is conducting this roundtable demonstrate...mers have access to safe and,affordable biogeneri...
(Date:11/21/2008)...re-USNewswire/ -- The University of Texas M. D. ...ollaborative effort to eradicate breast cancer in ...wareness and Research of the Americas today at an ...d States, and Vivian Fernandez de Torrijos, the Fi...son in the initiative are the U.S. Department of S...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research Extends to Panama 3(Date:11/20/2008)...re-FirstCall/ -- Duska Therapeutics,Inc., (OTC B...submitted its,pivotal Phase 3 ATPace clinical tri...ssessment (SPA) procedure with the U.S. Food and D...uring an agreement with the FDA, Duska intends to ...cebo-controlled and randomized Phase 3,clinical t...
(Date:11/20/2008)...Newswire/ -- The Scandinavian-based drug,developm...of studies on its,lead antimicrobial candidate LT...studies showed that the novel lytic peptidomimetic...cantly better towards killing Staphylococcus,aure...tandard drugs. In,addition to this it has proven ...
(Date:11/19/2008)...ndings on critical enzyme,s regulation may hold ke... disorders , , MEMPHIS, Tenn., Nov. 19 /PRN...ldren,s Research Hospital have gained new insights...orses called calpains. , , As the cell,s m...cellular processes, including the movement of cell...
(Date:11/18/2008)...stCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a speci...pment Company,and Sosei Group Corporation ("Sose...onal biopharmaceutical company, today announce tha...e-clinical efficacy data for NSL-043/SD118.,This ...uropathic pain and has,successfully completed Pha...
Breaking Medicine Technology:Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Chindex International Announces Shelf Registration Related Strategy and Guidance 5368 1Chindex International Announces Shelf Registration Related Strategy and Guidance 5368 2Chindex International Announces Shelf Registration Related Strategy and Guidance 5368 3Chindex International Announces Shelf Registration Related Strategy and Guidance 5368 4Chindex International Announces Shelf Registration Related Strategy and Guidance 5368 5Girls young women can cut risk of early breast cancer through regular exercise 19246 1Girls young women can cut risk of early breast cancer through regular exercise 19246 2Blood Thinner No Help for Dialysis Treatment 19243 1Blood Thinner No Help for Dialysis Treatment 19243 2Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 19240 1Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 19240 2Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 19240 3...007 - Columbia,Laboratories, Inc. (NASDAQ: CBRX) t...ngoing data analysis of the recently-completed,ran...I clinical,trial of PROCHIEVE(R) 8% (progesterone ...with a previous preterm birth earlier than,35 week...HIEVE 8%,in delaying cervical shortening. A short ...
...w study published today,in the New England Journal...stry Relationships") on the extent of doctor and,p...e need for,profession-wide and public policy refor...le concludes that the existing,voluntary PhRMA (P...a) Code isn,t working., The Prescription Project o...
Other Medicine Technology:Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 2Columbia Laboratories Reports Preliminary Findings from the Ongoing,Data Analysis of the Phase III Clinical Study of PROCHIEVE 8%,(progesterone gel) to Prevent Preterm Birth 3Ties Between Physicians and Drug Companies Still Too Strong: the,Prescription Project Offers Solutions to Prevent Conflicts of,Interest 2The Self-Cath family of 100% latex-free catheters offers patients a variety of options for intermittent self-catheterization. Each catheter is made of flexible medical grade PVC and has smooth fire
Used for intermittent catheterization of a male or female patient to provide drainage of urine from the bladder. Supplied sterile in peel-open packages. Intended for one-time use.
An indirect immunofluorescence antibody test for the detection and semi-quantitation of anti-neutrophil cytoplasmic antibodies (ANCA) in human serum. ANCA are found in the sera of patients with necro
Jerome Halo Traction Units provide optimum immobilization for unstable injuries of the spine. The Generation 80 superstructure is available with either 2-point (serrated disk), or 3-point (flexion/ex
Medicine Products: